# superDimension™ Navigation System Version 7.2 With Fluoroscopic Navigation Technology

> **NCT03585959** · NA · COMPLETED · sponsor: **Medtronic - MITG** · enrollment: 50 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DEVICE:** superDimension™ Navigation System Version 7.2

## Key facts

- **NCT ID:** NCT03585959
- **Lead sponsor:** Medtronic - MITG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-03
- **Primary completion:** 2019-02-13
- **Final completion:** 2019-02-18
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03585959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03585959, "superDimension™ Navigation System Version 7.2 With Fluoroscopic Navigation Technology". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT03585959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*